WPI 2282 (Zolpidem tartrate extended-release 12.5 mg)
Pill imprint WPI 2282 has been identified as Zolpidem tartrate extended-release 12.5 mg.
Zolpidem is used in the treatment of insomnia and belongs to the drug class miscellaneous anxiolytics, sedatives and hypnotics. Risk cannot be ruled out during pregnancy. Zolpidem 12.5 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
- WPI 2282
- 12.5 mg
- Prescription only
- Drug Class:
- Miscellaneous anxiolytics, sedatives and hypnotics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 4 - Some potential for abuse
- Watson Laboratories, Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose anhydrous
dimethylaminoethyl methacrylate - butyl methacrylate - methyl methacrylate copolymer
hydroxypropyl cellulose (type h)
methacrylic acid - ethyl acrylate copolymer (1:1) type a
sodium lauryl sulfate
More about zolpidem
- Zolpidem extended-release tablets
- Zolpidem spray
- Zolpidem (Advanced Reading)
- Zolpidem Oral, Oromucosal (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.